Dr Sarah U Laurente, MD | |
1009 Charity St, Abbeville, LA 70510-5302 | |
(337) 893-3443 | |
Not Available |
Full Name | Dr Sarah U Laurente |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 1009 Charity St, Abbeville, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881686277 | NPI | - | NPPES |
1430960 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 13797R (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sarah U Laurente, MD 806 Jefferson Ter, New Iberia, LA 70560-5727 Ph: (337) 365-4945 | Dr Sarah U Laurente, MD 1009 Charity St, Abbeville, LA 70510-5302 Ph: (337) 893-3443 |
News Archive
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells and circulating tumor DNA in cancer patients, reported the publication in the journal Cancer Medicine of a paper entitled "Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer" on research performed with collaborators from the University of Texas MD Anderson Cancer Center.
Tuberculosis (TB) has been present in humans since ancient times. The origins of the disease date back to the first domestication of cattle, and skeletal remains show prehistoric humans (4,000 B.C.) had TB. Although relatively rare in the United States, it is the single leading bacterial cause of death worldwide. Approximately 8 million people are infected each year and 2 million people die from TB.
A technique called size-fractionation performed on a sample of the mother's blood allows researchers to identify fetal DNA molecules separate from maternal DNA as a way to determine which pregnancies may be at risk for genetic disorders, according to a preliminary communication in the February 16 issue of JAMA, a theme issue on medical applications of biotechnology.
› Verified 6 days ago
Mr. Budi N Sugeng, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1305 N State St, Abbeville, LA 70510 Phone: 337-422-6240 Fax: 337-422-6241 |